Insightec has announced that Seoul National University Hospital (SNUH) is installing the company’s Exablate Neuro (Exablate 4000) platform—which uses focused ultrasound to ablate targets deep in the brain for a therapeutic effect.
“Focused Ultrasound provides a precision tool for neurosurgical treatments,” said Kim Seung-Ki, head of Neurosurgery at SNUH in Seoul, South Korea. “Clinical evidence has demonstrated a positive impact on patient quality of life with a favourable safety profile.”
“This is the first installation of our first-to-market focused ultrasound technology in a public hospital in South Korea,” added Ori Atar, director of Asia Growth Markets at Insightec. “It is exciting to know that more patients will now have access to an incisionless treatment option.”
There are 81 leading medical centres globally that have established focused ultrasound programmes with the Exablate Neuro platform, according to an Insightec press release. Insightec partners with Huons, a manufacturer of pharmaceutical products and distributor of medical solutions, to bring focused ultrasound to Korean healthcare systems.
“Bringing advanced technology that improves people’s health to the largest public hospital is a major milestone,” said Huons CEO Um Key-An. “Medical centres are realising the value that a focused ultrasound programme can bring to patient care.”
